Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024.
- Revenue
- +21.2%
- EPS
- −10.2%
- Free cash flow
- +23.4%
- Total debt
- +18.4%
Quarter to September 2026, against a year earlier
Follow WAY
Alert me
Waystar Holding Corp. (WAY) P/B ratio
As of 5 November 2026, Waystar Holding Corp. (WAY) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 0.8× (June 2026) to 2.3× (June 2025); the current reading is higher than 45% of that period. That is below the Health Information Services industry median of 1.9× and below the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 1.5× | (15.91%) |
| FY2024 | 1.8× | 45.40% |
| FY2023 | 1.2× | 0.00% |
| FY2022 | 1.2× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 1.2× | 21.93% |
| Jun 2026 | 1.0× | (15.80%) |
| Mar 2026 | 1.2× | (21.88%) |
| Dec 2025 | 1.5× | (26.77%) |
| 9 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| WAY Waystar Holding Corp. | 1.4× |
| PRVA Privia Health Group, Inc. compare | 3.5× |
| HQY HealthEquity, Inc. compare | 4.3× |
| BTSG BrightSpring Health Services, Inc. compare | 6.3× |
| DOCS Doximity, Inc. compare | 6.4× |
| SDGR Schrodinger, Inc. compare | 7.2× |
| HTFL Heartflow, Inc. compare | 16.1× |
| TEM Tempus AI, Inc. compare | 25.5× |
| HNGE Hinge Health Inc. compare | 26.6× |
| Health Information Services industry median | 1.9× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on WAY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement